Hormone Infusion Works in Older Individuals
JANUARY 01, 2004
Researchers have found a new way to help elderly patients with type 2 diabetes. A continuous infusion of glucagon-like peptide 1 (GLP-1) seems to help control glucose levels in the blood without lowering glucose too far. In order to test the safety and efficacy of GLP-1, the researchers evaluated 18 type 2 diabetics who were 75 years old on average. The group was randomly assigned to their usual course of oral treatment or to continuous GLP-1 infusion administered by a small portable pump. After 12 weeks of treatment, the researchers found that long-term glucose control remained stable in both groups. As for the occurrence of hypoglycemia, the study showed 87 episodes of hypoglycemia in the control group, compared with only 1 in the GLP-1 group.
AF Risk Increases with More Pregnancies
One study linked multiple pregnancies to an increased risk of developing atrial fibrillation later in life, and another investigated the association between premature delivery and cardiovascular disease.